Literature DB >> 28302626

STING-IRF3 Triggers Endothelial Inflammation in Response to Free Fatty Acid-Induced Mitochondrial Damage in Diet-Induced Obesity.

Yun Mao1, Wei Luo1, Lin Zhang1, Weiwei Wu1, Liangshuai Yuan1, Hao Xu1, Juhee Song1, Keigi Fujiwara1, Jun-Ichi Abe1, Scott A LeMaire1, Xing Li Wang1, Ying H Shen2.   

Abstract

OBJECTIVE: Metabolic stress in obesity induces endothelial inflammation and activation, which initiates adipose tissue inflammation, insulin resistance, and cardiovascular diseases. However, the mechanisms underlying endothelial inflammation induction are not completely understood. Stimulator of interferon genes (STING) is an important molecule in immunity and inflammation. In the present study, we sought to determine the role of STING in palmitic acid-induced endothelial activation/inflammation. APPROACH AND
RESULTS: In cultured endothelial cells, palmitic acid treatment activated STING, as indicated by its perinuclear translocation and binding to interferon regulatory factor 3 (IRF3), leading to IRF3 phosphorylation and nuclear translocation. The activated IRF3 bound to the promoter of ICAM-1 (intercellular adhesion molecule 1) and induced ICAM-1 expression and monocyte-endothelial cell adhesion. When analyzing the upstream signaling, we found that palmitic acid activated STING by inducing mitochondrial damage. Palmitic acid treatment caused mitochondrial damage and leakage of mitochondrial DNA into the cytosol. Through the cytosolic DNA sensor cGAS (cyclic GMP-AMP synthase), the mitochondrial damage and leaked cytosolic mitochondrial DNA activated the STING-IRF3 pathway and increased ICAM-1 expression. In mice with diet-induced obesity, the STING-IRF3 pathway was activated in adipose tissue. However, STING deficiency (Stinggt/gt ) partially prevented diet-induced adipose tissue inflammation, obesity, insulin resistance, and glucose intolerance.
CONCLUSIONS: The mitochondrial damage-cGAS-STING-IRF3 pathway is critically involved in metabolic stress-induced endothelial inflammation. STING may be a potential therapeutic target for preventing cardiovascular diseases and insulin resistance in obese individuals.
© 2017 American Heart Association, Inc.

Entities:  

Keywords:  DNA, mitochondrial; diet, high-fat; endothelium; palmitic acid; vascular diseases

Mesh:

Substances:

Year:  2017        PMID: 28302626      PMCID: PMC5408305          DOI: 10.1161/ATVBAHA.117.309017

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  42 in total

1.  Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription.

Authors:  M Bonnard; C Mirtsos; S Suzuki; K Graham; J Huang; M Ng; A Itié; A Wakeham; A Shahinian; W J Henzel; A J Elia; W Shillinglaw; T W Mak; Z Cao; W C Yeh
Journal:  EMBO J       Date:  2000-09-15       Impact factor: 11.598

2.  Intrinsic self-DNA triggers inflammatory disease dependent on STING.

Authors:  Jeonghyun Ahn; Phillip Ruiz; Glen N Barber
Journal:  J Immunol       Date:  2014-09-26       Impact factor: 5.422

3.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.

Authors:  H O Steinberg; G Paradisi; G Hook; K Crowder; J Cronin; A D Baron
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

4.  Endoplasmic reticulum stress regulates the innate immunity critical transcription factor IRF3.

Authors:  Yi-Ping Liu; Ling Zeng; Austin Tian; Ashley Bomkamp; Daniel Rivera; Delia Gutman; Glen N Barber; Julie K Olson; Judith A Smith
Journal:  J Immunol       Date:  2012-10-01       Impact factor: 5.422

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 6.  Mitochondria and cardiovascular aging.

Authors:  Dao-Fu Dai; Peter S Rabinovitch; Zoltan Ungvari
Journal:  Circ Res       Date:  2012-04-13       Impact factor: 17.367

7.  Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway.

Authors:  Lijun Sun; Jiaxi Wu; Fenghe Du; Xiang Chen; Zhijian J Chen
Journal:  Science       Date:  2012-12-20       Impact factor: 47.728

8.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity.

Authors:  Hiroki Ishikawa; Zhe Ma; Glen N Barber
Journal:  Nature       Date:  2009-09-23       Impact factor: 49.962

Review 9.  Dietary fat, fatty acid composition in plasma and the metabolic syndrome.

Authors:  Bengt Vessby
Journal:  Curr Opin Lipidol       Date:  2003-02       Impact factor: 4.776

10.  STING manifests self DNA-dependent inflammatory disease.

Authors:  Jeonghyun Ahn; Delia Gutman; Shinobu Saijo; Glen N Barber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-06       Impact factor: 11.205

View more
  63 in total

1.  Expression of STING Is Increased in Liver Tissues From Patients With NAFLD and Promotes Macrophage-Mediated Hepatic Inflammation and Fibrosis in Mice.

Authors:  Xianjun Luo; Honggui Li; Linqiang Ma; Jing Zhou; Xin Guo; Shih-Lung Woo; Ya Pei; Linda R Knight; Michael Deveau; Yanming Chen; Xiaoxian Qian; Xiaoqiu Xiao; Qifu Li; Xiangbai Chen; Yuqing Huo; Kelly McDaniel; Heather Francis; Shannon Glaser; Fanyin Meng; Gianfranco Alpini; Chaodong Wu
Journal:  Gastroenterology       Date:  2018-09-10       Impact factor: 22.682

2.  STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis.

Authors:  Yongsheng Yu; Yu Liu; Weishuai An; Jingwen Song; Yuefan Zhang; Xianxian Zhao
Journal:  J Clin Invest       Date:  2018-12-18       Impact factor: 14.808

3.  The non-transcriptional activity of IRF3 modulates hepatic immune cell populations in acute-on-chronic ethanol administration in mice.

Authors:  Carlos Sanz-Garcia; Kyle L Poulsen; Damien Bellos; Han Wang; Megan R McMullen; Xiaoxia Li; Saurabh Chattopadhyay; Ganes Sen; Laura E Nagy
Journal:  J Hepatol       Date:  2019-01-31       Impact factor: 25.083

Review 4.  Decoding the rosetta stone of mitonuclear communication.

Authors:  Justin English; Jyung Mean Son; Maria Dafne Cardamone; Changhan Lee; Valentina Perissi
Journal:  Pharmacol Res       Date:  2020-08-23       Impact factor: 7.658

5.  Palmitic acid dysregulates the Hippo-YAP pathway and inhibits angiogenesis by inducing mitochondrial damage and activating the cytosolic DNA sensor cGAS-STING-IRF3 signaling mechanism.

Authors:  Liangshuai Yuan; Yun Mao; Wei Luo; Weiwei Wu; Hao Xu; Xing Li Wang; Ying H Shen
Journal:  J Biol Chem       Date:  2017-07-11       Impact factor: 5.157

Review 6.  Targeting mitochondria for cardiovascular disorders: therapeutic potential and obstacles.

Authors:  Massimo Bonora; Mariusz R Wieckowski; David A Sinclair; Guido Kroemer; Paolo Pinton; Lorenzo Galluzzi
Journal:  Nat Rev Cardiol       Date:  2019-01       Impact factor: 32.419

7.  Reporting Sex and Sex Differences in Preclinical Studies.

Authors:  Hong S Lu; Ann Marie Schmidt; Robert A Hegele; Nigel Mackman; Daniel J Rader; Christian Weber; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-10       Impact factor: 8.311

Review 8.  Emerging Roles for Adipose Tissue in Cardiovascular Disease.

Authors:  Elizabeth E Ha; Robert C Bauer
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-08       Impact factor: 8.311

9.  Critical Role of Cytosolic DNA and Its Sensing Adaptor STING in Aortic Degeneration, Dissection, and Rupture.

Authors:  Wei Luo; Yidan Wang; Lin Zhang; Pingping Ren; Chen Zhang; Yanming Li; Alon R Azares; Michelle Zhang; Jiao Guo; Ketan B Ghaghada; Zbigniew A Starosolski; Kimal Rajapakshe; Cristian Coarfa; Yumei Li; Rui Chen; Keigi Fujiwara; Jun-Ichi Abe; Joseph S Coselli; Dianna M Milewicz; Scott A LeMaire; Ying H Shen
Journal:  Circulation       Date:  2019-12-30       Impact factor: 29.690

10.  Metabolism, Obesity, and Diabetes Mellitus.

Authors:  Henry H Ruiz; Raquel López Díez; Lakshmi Arivazahagan; Ravichandran Ramasamy; Ann Marie Schmidt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-06-26       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.